FOXP3 and myeloid sarcoma: Thus, impaired glycolysis in MS patients has been shown to result in reduced FoxP3 expression in Tregs impeding their suppressive function [60,62,63], while inhibiting glycolysis in EAE mice reduced disease burden and the release of proinflammatory cytokines [82].